William Migo, Marko Boskovic, & Robert Likic. (2021). The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response. Elsevier.
Chicago Style (17th ed.) CitationWilliam Migo, Marko Boskovic, and Robert Likic. The Development of Biologics to Target SARS-CoV2: Treatment Potential of Antibodies in Patient Groups with Poor Immune Response. Elsevier, 2021.
MLA (9th ed.) CitationWilliam Migo, et al. The Development of Biologics to Target SARS-CoV2: Treatment Potential of Antibodies in Patient Groups with Poor Immune Response. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.